Lymphoma Clinical Trials in Baltimore
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +33 more
- Birmingham, Alabama
- +1423 more
2022-04-06
Apr 6, 2022N
Recruiting
- Lymphoma
- +6 more
- Cytology Specimen Collection Procedure
- Birmingham, Alabama
- +139 more
2022-04-05
Apr 5, 2022J
C
Active, not recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +3 more
- Birmingham, Alabama
- +42 more
2022-03-22
Mar 22, 2022I
Active, not recruiting
- Lymphoma
- Scottsdale, Arizona
- +20 more
2022-03-08
Mar 8, 2022I
Completed
- Lymphoma
- Birmingham, Alabama
- +69 more
2022-02-28
Feb 28, 2022E
Active, not recruiting
- Lymphoma
- rituximab
- +3 more
- Greenbrae, California
- +226 more
2022-03-07
Mar 7, 2022B
Completed
- Lymphoma
- Acute Lymphoblastic Leukemia
- Apixaban
- No systemic anticoagulant prophylaxis
- Phoenix, Arizona
- +95 more
2022-02-10
Feb 10, 2022C
Recruiting
- Acute Lymphoblastic Leukemia
- +13 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
- Birmingham, Alabama
- +68 more
2022-03-03
Mar 3, 2022N
Active, not recruiting
- Glioma
- +49 more
- Pharmacological Study
- Romidepsin
- Duarte, California
- +11 more
2022-03-01
Mar 1, 2022C
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Busulfan
- +11 more
- Duarte, California
- +16 more
2022-02-25
Feb 25, 2022S
Recruiting
- Leukemia
- +5 more
- Bone Marrow Transplant (BMT)
- Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2022-02-14
Feb 14, 2022I
Completed
- Microsatellite-instability (MSI) High Colorectal Cancer (CRC)
- +13 more
- La Jolla, California
- +23 more
2022-02-11
Feb 11, 2022I
Active, not recruiting
- Lymphoma
- Phoenix, Arizona
- +82 more
2022-01-14
Jan 14, 2022A
Active, not recruiting
- Solid Tumors
- Lymphoma
- Birmingham, Alabama
- +68 more
2022-01-24
Jan 24, 2022M
Completed
- Lymphoma
- HIV
- Autologous transplant
- +4 more
- Duarte, California
- +15 more
2022-01-25
Jan 25, 2022S
Active, not recruiting
- Lymphoma
- Nonneoplastic Condition
- bleomycin sulfate
- +11 more
- Tucson, Arizona
- +422 more
2022-01-19
Jan 19, 2022E
Active, not recruiting
- Lymphoma
- +2 more
- rituximab
- +3 more
- Anchorage, Alaska
- +417 more
2021-12-29
Dec 29, 2021A
H
R
Active, not recruiting
- Chemotherapeutic Agent Toxicity
- +4 more
- Rituximab
- +5 more
- Birmingham, Alabama
- +44 more
2021-11-02
Nov 2, 2021M
Active, not recruiting
- Acute Leukemia
- +3 more
- Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
- +5 more
- Birmingham, Alabama
- +38 more
2021-10-25
Oct 25, 2021M
Withdrawn
- Lymphoma
- rituximab
- +7 more
- Washington, District of Columbia
- +1 more
2021-10-19
Oct 19, 2021C
Terminated
- Lymphoma
- ACTR707
- rituximab
- Gilbert, Arizona
- +10 more
2021-10-04
Oct 4, 2021S
Active, not recruiting
- Lymphoma
- rituximab
- +5 more
- Anchorage, Alaska
- +258 more
2021-09-21
Sep 21, 2021